Qingsong Gao

1. IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response
   2026/03/27 by Sonja Bendig, Alina Hartmann, Wiebke Wessels +25 · 1 voice
   Medicine · #Acute Lymphoblastic Leukemia research #Chronic Myeloid Leukemia Treatments #Lymphoma Diagnosis and Treatment
2. The ASH HematOmics Program supports integrative analysis of genomic and clinical data in hematologic diseases
   2026/04/06 by Congyu Lu, Gavriel Y. Matt, Robin Paul +20 · 1 voice
   Biochemistry, Genetics and Molecular Biology · Medicine · #Acute Lymphoblastic Leukemia research #Acute Myeloid Leukemia Research #Genomics and Rare Diseases